Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05719285 · ClinicalTrials.gov registry record · Phase 4
Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection
A Phase 4 study of Overactive Bladder and Overactive Bladder Syndrome, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05719285 is a Phase 4 study of Overactive Bladder and Overactive Bladder Syndrome that has completed, run by The Cleveland Clinic. The registered enrollment target is 100 participants, below the 209-participant average among 45 other Overactive Bladder trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05719285, a Phase 4 study of Overactive Bladder and Overactive Bladder Syndrome, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate the outcomes of differing durations of antibiotic prophylaxis with bladder onabotulinumtoxinA injection in patients with refractory overactive bladder. The main question it aims to answer are: • Is the incidence of post-procedure UTI similar between single-dose and multi-day durations of peri-procedural antibiotics? Participants will be randomized to single-dose versus multi-day dose of antibiotic prophylaxis with bladder onabotulinumtoxinA injection. Researchers will compare incidence of UTI in each group to see if there is a significant difference.
Conditions Studied
Interventions
- DRUG Single-Dose Antibiotic
- DRUG Multi-Dose Antibiotic
Study Locations (1)
Ohio
- Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-12-06 |
| Est. Completion | 2023-06-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05719285
The ClinicalTrials.gov registry entry for NCT05719285 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 209-participant average among 45 other Overactive Bladder trials with a reported enrollment target (52% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Overactive Bladder appearing as the primary indexed condition, and to 2 interventions - of which Single-Dose Antibiotic is the first listed.
NCT05719285 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05719285 about?
NCT05719285 is a clinical study titled "Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection". The goal of this clinical trial is to evaluate the outcomes of differing durations of antibiotic prophylaxis with bladder onabotulinumtoxinA injection in patients with refractory overactive bladder. The main question it aims to answer are: • Is the incidence of post-procedure UTI similar between s...
What is the current status of trial NCT05719285?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2022-12-06. Estimated completion is 2023-06-08.
What conditions does trial NCT05719285 study?
This clinical trial studies the following conditions: Overactive Bladder, Overactive Bladder Syndrome, Urinary Incontinence, Urge, Urge Incontinence.
What interventions are being tested in trial NCT05719285?
The interventions under investigation include: Single-Dose Antibiotic (DRUG), Multi-Dose Antibiotic (DRUG).
Who is sponsoring clinical trial NCT05719285?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05719285 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overactive Bladder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Bladder Botox UTI Antibiotic Prophylaxis
RECRUITING · Phase 4
-
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
RECRUITING · Phase 4
-
Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks
RECRUITING · Phase 4
-
TReating Incontinence for Underlying Mental and Physical Health
RECRUITING · Phase 4
-
Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder
COMPLETED · Phase 4
-
Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.
COMPLETED · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.